Quest Diagnostics Inc Selling, General and Administrative Expense
Quest Diagnostics Inc (DGX) reported Selling, General and Administrative Expense of $529.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-07-23
- Quest Diagnostics Inc selling, general and administrative expense for the quarter ending 2026-06-30 was $529.00M, a 8.85% increase year-over-year.
- Quest Diagnostics Inc selling, general and administrative expense for the quarter ending 2026-03-31 was $504.00M, a 5.88% increase year-over-year.
- Quest Diagnostics Inc selling, general and administrative expense for the quarter ending 2025-12-31 was $504.00M, a 8.15% increase year-over-year.
- Quest Diagnostics Inc selling, general and administrative expense for the quarter ending 2025-09-30 was $501.00M, a 11.83% increase year-over-year.
- Quest Diagnostics Inc selling, general and administrative expense for fiscal 2025 was $1.97B, a 11.13% increase from fiscal 2024.
- Quest Diagnostics Inc selling, general and administrative expense for fiscal 2024 was $1.77B, a 7.80% increase from fiscal 2023.
- Quest Diagnostics Inc selling, general and administrative expense for fiscal 2023 was $1.64B, a 12.38% decline from fiscal 2022.
- Quest Diagnostics Inc selling, general and administrative expense for fiscal 2022 was $1.87B, a 8.51% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $529.00M 10-Q · filed 2026-07-23 | $1.03B 10-Q · filed 2026-07-23 | $1.54B derived: sum of 3 quarters · filed 2026-07-23 | $2.04B derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2026-03-31 | $504.00M 10-Q · filed 2026-04-22 | $1.01B derived: sum of 2 quarters · filed 2026-04-22 | $1.51B derived: sum of 3 quarters · filed 2026-04-22 | $2.00B derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-12-31 | $504.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.00B derived: sum of 2 quarters · filed 2026-02-26 | $1.49B derived: sum of 3 quarters · filed 2026-07-23 | $1.97B 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $501.00M 10-Q · filed 2025-10-21 | $987.00M derived: sum of 2 quarters · filed 2026-07-23 | $1.46B 10-Q · filed 2025-10-21 | $1.93B derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-06-30 | $486.00M 10-Q · filed 2026-07-23 | $962.00M 10-Q · filed 2026-07-23 | $1.43B derived: sum of 3 quarters · filed 2026-07-23 | $1.88B derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-03-31 | $476.00M 10-Q · filed 2026-04-22 | $942.00M derived: sum of 2 quarters · filed 2026-04-22 | $1.39B derived: sum of 3 quarters · filed 2026-04-22 | $1.81B derived: sum of 4 quarters · filed 2026-04-22 | ||||
| 2024-12-31 | $466.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $914.00M derived: sum of 2 quarters · filed 2026-02-26 | $1.33B derived: sum of 3 quarters · filed 2026-02-26 | $1.77B 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $448.00M 10-Q · filed 2025-10-21 | $864.00M derived: sum of 2 quarters · filed 2025-10-21 | $1.30B 10-Q · filed 2025-10-21 | $1.71B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $416.00M 10-Q · filed 2025-07-23 | $856.00M 10-Q · filed 2025-07-23 | $1.26B derived: sum of 3 quarters · filed 2026-02-26 | $1.64B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $440.00M 10-Q · filed 2025-04-23 | $847.00M derived: sum of 2 quarters · filed 2026-02-26 | $1.23B derived: sum of 3 quarters · filed 2026-02-26 | $1.64B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $407.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $787.00M derived: sum of 2 quarters · filed 2026-02-26 | $1.20B derived: sum of 3 quarters · filed 2026-02-26 | $1.64B 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $380.00M 10-Q · filed 2024-10-23 | $796.00M derived: sum of 2 quarters · filed 2024-10-23 | $1.24B 10-Q · filed 2024-10-23 | $1.80B derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-06-30 | $416.00M 10-Q · filed 2024-07-24 | $855.00M 10-Q · filed 2024-07-24 | $1.42B derived: sum of 3 quarters · filed 2025-02-20 | $1.88B derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-03-31 | $439.00M 10-Q · filed 2024-04-24 | $1.00B derived: sum of 2 quarters · filed 2025-02-20 | $1.47B derived: sum of 3 quarters · filed 2025-02-20 | $1.89B derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2022-12-31 | $563.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $1.03B derived: sum of 2 quarters · filed 2025-02-20 | $1.45B derived: sum of 3 quarters · filed 2025-02-20 | $1.87B 10-K · filed 2025-02-20 | ||||
| 2022-09-30 | $464.00M 10-Q · filed 2023-10-25 | $886.00M derived: sum of 2 quarters · filed 2023-10-25 | $1.31B 10-Q · filed 2023-10-25 | $1.77B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-06-30 | $422.00M 10-Q · filed 2023-07-27 | $847.00M 10-Q · filed 2023-07-27 | $1.31B derived: sum of 3 quarters · filed 2024-02-22 | $1.74B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-03-31 | $425.00M 10-Q · filed 2023-04-28 | $889.00M derived: sum of 2 quarters · filed 2024-02-22 | $1.32B derived: sum of 3 quarters · filed 2024-02-22 | $1.75B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | $464.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $891.00M derived: sum of 2 quarters · filed 2024-02-22 | $1.32B derived: sum of 3 quarters · filed 2024-02-22 | $1.73B 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | $427.00M 10-Q · filed 2022-10-21 | $856.00M derived: sum of 2 quarters · filed 2022-10-21 | $1.26B 10-Q · filed 2022-10-21 | $1.71B derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-06-30 | $429.00M 10-Q · filed 2022-07-22 | $836.00M 10-Q · filed 2022-07-22 | $1.28B derived: sum of 3 quarters · filed 2023-02-21 | $1.68B derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-03-31 | $407.00M 10-Q · filed 2022-04-22 | $854.00M derived: sum of 2 quarters · filed 2023-02-21 | $1.25B derived: sum of 3 quarters · filed 2023-02-21 | $1.61B derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2020-12-31 | $447.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $843.00M derived: sum of 2 quarters · filed 2023-02-21 | $1.20B derived: sum of 3 quarters · filed 2023-02-21 | $1.55B 10-K · filed 2023-02-21 | ||||
| 2020-09-30 | $396.00M 10-Q · filed 2021-10-22 | $756.00M derived: sum of 2 quarters · filed 2021-10-22 | $1.10B 10-Q · filed 2021-10-22 | $1.45B derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-06-30 | $360.00M 10-Q · filed 2021-07-23 | $707.00M 10-Q · filed 2021-07-23 | $1.06B derived: sum of 3 quarters · filed 2022-02-28 | $1.42B derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-03-31 | $347.00M 10-Q · filed 2021-04-23 | $696.00M derived: sum of 2 quarters · filed 2022-02-28 | $1.06B derived: sum of 3 quarters · filed 2022-02-28 | $1.42B derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | $349.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $711.00M derived: sum of 2 quarters · filed 2022-02-28 | $1.07B derived: sum of 3 quarters · filed 2022-02-28 | $1.46B 10-K · filed 2022-02-28 | ||||
| 2019-09-30 | $362.00M 10-Q · filed 2020-10-23 | $724.00M derived: sum of 2 quarters · filed 2020-10-23 | $1.11B 10-Q · filed 2020-10-23 | $1.46B derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-06-30 | $362.00M 10-Q · filed 2020-07-24 | $746.00M 10-Q · filed 2020-07-24 | $1.10B derived: sum of 3 quarters · filed 2021-02-22 | $1.46B derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-03-31 | $384.00M 10-Q · filed 2020-05-04 | $740.00M derived: sum of 2 quarters · filed 2021-02-22 | $1.09B derived: sum of 3 quarters · filed 2021-02-22 | $1.45B derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2018-12-31 | $356.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $710.00M derived: sum of 2 quarters · filed 2021-02-22 | $1.06B derived: sum of 3 quarters · filed 2021-02-22 | $1.42B 10-K · filed 2021-02-22 | ||||
| 2018-09-30 | $354.00M 10-Q · filed 2019-10-23 | $705.00M derived: sum of 2 quarters · filed 2019-10-23 | $1.07B 10-Q · filed 2019-10-23 | $1.45B derived: sum of 4 quarters · filed 2020-02-20 | ||||
| 2018-06-30 | $351.00M 10-Q · filed 2019-07-24 | $714.00M 10-Q · filed 2019-07-24 | $1.10B derived: sum of 3 quarters · filed 2020-02-20 | $1.44B derived: sum of 4 quarters · filed 2020-02-20 | ||||
| 2018-03-31 | $363.00M 10-Q · filed 2019-04-24 | $745.00M derived: sum of 2 quarters · filed 2020-02-20 | $1.09B derived: sum of 3 quarters · filed 2020-02-20 | $1.45B derived: sum of 4 quarters · filed 2020-02-20 | ||||
| 2017-12-31 | $382.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $730.00M derived: sum of 2 quarters · filed 2020-02-20 | $1.09B derived: sum of 3 quarters · filed 2020-02-20 | $1.44B 10-K · filed 2020-02-20 | $1.75B 10-K · filed 2018-02-23 | |||
| 2017-09-30 | $348.00M 10-Q · filed 2018-10-24 | $423.00M 10-Q · filed 2017-10-19 | $706.00M derived: sum of 2 quarters · filed 2018-10-24 | $1.06B 10-Q · filed 2018-10-24 | $1.30B 10-Q · filed 2017-10-19 | $1.16B derived: sum of 4 quarters · filed 2019-02-21 | ||
| 2017-06-30 | $358.00M 10-Q · filed 2018-07-25 | $437.00M 10-Q · filed 2017-07-25 | $713.00M 10-Q · filed 2018-07-25 | $874.00M 10-Q · filed 2017-07-25 | $812.00M derived: sum of 3 quarters · filed 2019-02-21 | $1.22B derived: sum of 4 quarters · filed 2019-02-21 | ||
| 2017-03-31 | $355.00M 10-Q · filed 2018-04-20 | $437.00M 10-Q · filed 2017-04-21 | $454.00M derived: sum of 2 quarters · filed 2019-02-21 | $863.00M derived: sum of 3 quarters · filed 2019-02-21 | $1.29B derived: sum of 4 quarters · filed 2019-02-21 | |||
| 2016-12-31 | $99.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $508.00M derived: sum of 2 quarters · filed 2019-02-21 | $938.00M derived: sum of 3 quarters · filed 2019-02-21 | $1.38B 10-K · filed 2019-02-21 | $1.68B 10-K · filed 2017-02-22 | |||
| 2016-09-30 | $409.00M 10-Q · filed 2017-10-19 | $839.00M derived: sum of 2 quarters · filed 2017-10-19 | $1.28B 10-Q · filed 2017-10-19 | $1.71B derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2016-06-30 | $430.00M 10-Q · filed 2017-07-25 | $872.00M 10-Q · filed 2017-07-25 | $1.30B derived: sum of 3 quarters · filed 2018-02-23 | $1.70B derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2016-03-31 | $442.00M 10-Q · filed 2017-04-21 | $871.00M derived: sum of 2 quarters · filed 2018-02-23 | $1.27B derived: sum of 3 quarters · filed 2018-02-23 | $1.70B derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2015-12-31 | $429.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $831.00M derived: sum of 2 quarters · filed 2018-02-23 | $1.26B derived: sum of 3 quarters · filed 2018-02-23 | $1.68B 10-K · filed 2018-02-23 | ||||
| 2015-09-30 | $402.00M 10-Q · filed 2016-10-21 | $831.00M derived: sum of 2 quarters · filed 2016-10-21 | $1.25B 10-Q · filed 2016-10-21 | $1.68B derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2015-06-30 | $429.00M 10-Q · filed 2016-07-25 | $848.00M 10-Q · filed 2016-07-25 | $1.27B derived: sum of 3 quarters · filed 2017-02-22 | $1.72B derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2015-03-31 | $419.00M 10-Q · filed 2016-04-27 | $846.00M derived: sum of 2 quarters · filed 2017-02-22 | $1.29B derived: sum of 3 quarters · filed 2017-02-22 | $1.73B derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2014-12-31 | $427.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $873.00M derived: sum of 2 quarters · filed 2017-02-22 | $1.31B derived: sum of 3 quarters · filed 2017-02-22 | $1.73B 10-K · filed 2017-02-22 | ||||
| 2014-09-30 | $446.00M 10-Q · filed 2015-10-29 | $886.00M derived: sum of 2 quarters · filed 2015-10-29 | $1.30B 10-Q · filed 2015-10-29 | $1.72B derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | $440.00M 10-Q · filed 2015-07-30 | $855.00M 10-Q · filed 2015-07-30 | $1.27B derived: sum of 3 quarters · filed 2016-02-26 | $1.69B derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | $415.00M 10-Q · filed 2015-04-30 | $830.00M derived: sum of 2 quarters · filed 2016-02-26 | $1.25B derived: sum of 3 quarters · filed 2016-02-26 | $1.67B derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $415.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $838.00M derived: sum of 2 quarters · filed 2016-02-26 | $1.26B derived: sum of 3 quarters · filed 2016-02-26 | $1.70B 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | $423.00M 10-Q · filed 2014-10-30 | $422.96M 10-Q · filed 2013-10-24 | $841.00M derived: sum of 2 quarters · filed 2014-10-30 | $1.29B 10-Q · filed 2014-10-30 | $1.29B 10-Q · filed 2013-10-24 | $1.71B derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-06-30 | $418.00M 10-Q · filed 2014-07-31 | $418.55M 10-Q · filed 2013-07-25 | $866.00M 10-Q · filed 2014-07-31 | $866.41M 10-Q · filed 2013-07-25 | $1.29B derived: sum of 3 quarters · filed 2015-02-24 | $1.70B derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-03-31 | $448.00M 10-Q · filed 2014-05-01 | $447.87M 10-Q · filed 2013-04-24 | $868.81M derived: sum of 2 quarters · filed 2015-02-24 | $1.29B derived: sum of 3 quarters · filed 2015-02-24 | $1.71B derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2012-12-31 | $420.81M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $837.66M derived: sum of 2 quarters · filed 2015-02-24 | $1.26B derived: sum of 3 quarters · filed 2015-02-24 | $1.75B 10-K · filed 2015-02-24 | $1.75B 10-K · filed 2013-02-27 | |||
| 2012-09-30 | $416.85M 10-Q · filed 2013-10-24 | $432.63M 10-Q · filed 2012-10-24 | $840.94M derived: sum of 2 quarters · filed 2013-10-24 | $1.32B 10-Q · filed 2013-10-24 | $1.37B 10-Q · filed 2012-10-24 | $1.71B derived: sum of 4 quarters · filed 2014-02-18 | ||
| 2012-06-30 | $424.08M 10-Q · filed 2013-07-25 | $440.79M 10-Q · filed 2012-07-26 | $907.34M 10-Q · filed 2013-07-25 | $941.43M 10-Q · filed 2012-07-26 | $1.29B derived: sum of 3 quarters · filed 2014-02-18 | $1.74B derived: sum of 4 quarters · filed 2014-02-18 | ||
| 2012-03-31 | $483.25M 10-Q · filed 2013-04-24 | $500.64M 10-Q · filed 2012-04-27 | $869.01M derived: sum of 2 quarters · filed 2014-02-18 | $1.32B derived: sum of 3 quarters · filed 2014-02-18 | $1.78B derived: sum of 4 quarters · filed 2014-02-18 | |||
| 2011-12-31 | $385.76M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | $832.35M derived: sum of 2 quarters · filed 2014-02-18 | $1.30B derived: sum of 3 quarters · filed 2014-02-18 | $1.74B 10-K · filed 2014-02-18 | $1.81B 10-K · filed 2012-02-16 | |||
| 2011-09-30 | $446.60M 10-Q · filed 2012-10-24 | $909.38M derived: sum of 2 quarters · filed 2012-10-24 | $1.36B 10-Q · filed 2012-10-24 | $1.74B derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-06-30 | $462.79M 10-Q · filed 2012-07-26 | $910.65M 10-Q · filed 2012-07-26 | $1.29B derived: sum of 3 quarters · filed 2013-02-27 | $1.72B derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-03-31 | $447.86M 10-Q · filed 2012-04-27 | $829.99M derived: sum of 2 quarters · filed 2013-02-27 | $1.26B derived: sum of 3 quarters · filed 2013-02-27 | $1.68B derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2010-12-31 | $382.13M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $808.70M derived: sum of 2 quarters · filed 2013-02-27 | $1.23B derived: sum of 3 quarters · filed 2013-02-27 | $1.66B 10-K · filed 2013-02-27 | $1.71B 10-K · filed 2011-02-16 | |||
| 2010-09-30 | $426.56M 10-Q · filed 2011-11-03 | $845.97M derived: sum of 2 quarters · filed 2011-11-03 | $1.28B 10-Q · filed 2011-11-03 | $1.71B derived: sum of 4 quarters · filed 2012-02-16 | ||||
| 2010-06-30 | $419.41M 10-Q · filed 2011-07-27 | $850.14M 10-Q · filed 2011-07-27 | $1.28B derived: sum of 3 quarters · filed 2012-02-16 | $1.72B derived: sum of 4 quarters · filed 2012-02-16 | ||||
| 2010-03-31 | $430.73M 10-Q · filed 2011-05-10 | $863.73M derived: sum of 2 quarters · filed 2012-02-16 | $1.31B derived: sum of 3 quarters · filed 2012-02-16 | $1.75B derived: sum of 4 quarters · filed 2012-02-16 | ||||
| 2009-12-31 | $432.99M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-16 | $874.56M derived: sum of 2 quarters · filed 2012-02-16 | $1.32B derived: sum of 3 quarters · filed 2012-02-16 | $1.75B 10-K · filed 2012-02-16 | ||||
| 2009-09-30 | $441.57M 10-Q · filed 2010-10-26 | $890.33M derived: sum of 2 quarters · filed 2010-10-26 | $1.31B 10-Q · filed 2010-10-26 | $1.75B derived: sum of 4 quarters · filed 2011-02-16 | ||||
| 2009-06-30 | $448.76M 10-Q · filed 2010-07-27 | $873.06M 10-Q · filed 2010-07-27 | $1.31B derived: sum of 3 quarters · filed 2011-02-16 | $1.74B derived: sum of 4 quarters · filed 2011-02-16 | ||||
| 2009-03-31 | $424.30M 10-Q · filed 2010-04-26 | $859.94M derived: sum of 2 quarters · filed 2011-02-16 | $1.29B derived: sum of 3 quarters · filed 2011-02-16 | $1.73B derived: sum of 4 quarters · filed 2011-02-16 | ||||
| 2008-12-31 | $435.64M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-16 | $863.82M derived: sum of 2 quarters · filed 2011-02-16 | $1.30B derived: sum of 3 quarters · filed 2011-02-16 | $1.74B 10-K · filed 2011-02-16 | ||||
| 2008-09-30 | $428.18M 10-Q · filed 2009-10-27 | $866.22M derived: sum of 2 quarters · filed 2009-10-27 | $1.30B 10-Q · filed 2009-10-27 | |||||
| 2008-06-30 | $438.04M 10-Q · filed 2009-07-28 | $873.12M 10-Q · filed 2009-07-28 | ||||||
| 2007-12-31 | $1.61B 10-K · filed 2010-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |